scholarly article | Q13442814 |
P50 | author | Mark Bounthavong | Q55362991 |
Rashid Kazerooni | Q56999281 | ||
P2093 | author name string | Jonathan H Watanabe | |
P2860 | cites work | Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association | Q22306356 |
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins | Q29547856 | ||
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators | Q29547887 | ||
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study | Q29617822 | ||
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group | Q29619842 | ||
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels | Q29620696 | ||
Does medication adherence lower Medicare spending among beneficiaries with diabetes? | Q35089645 | ||
Discontinuation and switching of therapy after initiation of lipid-lowering drugs: the effects of comorbidities and patient characteristics | Q35825588 | ||
Effects of increased patient cost sharing on socioeconomic disparities in health care | Q36840933 | ||
The demand for statin: the effect of copay on utilization and compliance. | Q36856495 | ||
Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans. | Q37365655 | ||
Simulated value-based insurance design applied to statin use by Medicare beneficiaries with diabetes | Q37394557 | ||
Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment | Q42616762 | ||
The effect of a large regional health plan's value-based insurance design program on statin use. | Q42671804 | ||
Effect of increased copayments on pharmacy use in the Department of Veterans Affairs | Q45332124 | ||
Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study. | Q51719123 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | socioeconomics | Q1643441 |
P304 | page(s) | 1463-1470 | |
P577 | publication date | 2013-10-10 | |
P1433 | published in | Annals of Pharmacotherapy | Q4767858 |
P1476 | title | Association of copayment and statin adherence stratified by socioeconomic status | |
P478 | volume | 47 |
Q61956042 | Determinants of Cost-Related Nonadherence to Medications among Chronically Ill Patients in Maccabi Healthcare Services, Israel |
Q38752985 | Financial strain is associated with medication nonadherence and worse self-rated health among cardiovascular patients |
Q90106686 | Inequalities in medication adherence to statin treatment after stroke: A nationwide observational study |
Q35158704 | Optimizing enrollment in employer health programs: a comparison of enrollment strategies in the Diabetes Health Plan |
Q37167826 | Value-Based Insurance Design: Aligning Incentives to Improve Cardiovascular Care |
Search more.